プロモーションスケジュール Kazia Therapeutics Limited
詳細なスケジュール
簡易グラフ
会社について Kazia Therapeutics Limited
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia.| IPO date | 1999-01-06 |
|---|---|
| ISIN | US48669G1058 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | aud |
| Див.доход ао | 53.19 |
| Дивиденд ао | 4.09 |
| Сайт | https://www.kaziatherapeutics.com |
| Цена ао | 0.96 |
| 1日あたりの価格変動: | 0% (0.9952) |
|---|---|
| 週ごとの価格変動: | +4.79% (0.9497) |
| 月ごとの料金変更: | +5.91% (0.9397) |
| 3ヶ月間の価格変動: | -70.11% (3.33) |
| 半年間の価格変動: | +192.71% (0.34) |
| 年間の価格変動: | +290.43% (0.2549) |
| 3年間の価格推移: | -83.55% (6.05) |
| 5年間の価格推移: | -75.27% (4.0238) |
| 年初からの価格変動: | -67.05% (3.02) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| 機関 | 音量 | 共有, % |
|---|---|---|
| Armistice Capital, LLC | 2475555 | 10.47 |
| Platinum Investment Management Ltd | 1821887 | 7.71 |
| Morgan Stanley | 201550 | 0.85 |
| Bank of Montreal/Can/ | 140166 | 0.59 |
| HSBC Holdings PLC | 100194 | 0.42 |
| TWO SIGMA SECURITIES, LLC | 58423 | 0.25 |
| XTX Topco Ltd | 19436 | 0.08 |
| Acadian Asset Management. LLC | 18682 | 0.08 |
| Citadel Advisors Llc | 12809 | 0.05 |
| BNP Paribas Financial Markets | 12700 | 0.05 |
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Ms. Anna Sandham | Company Secretary | N/A | |
| Dr. John Edwin Friend II, M.D. | CEO, MD & Director | 731.09k | 1970 (55 年) |
| Ms. Gabrielle Heaton BBUS (ACC), CPA | Principal Accounting Officer, VP of Finance & Administration and Principal Financial Officer | 178.56k |
住所: Australia, Sydney, Three International Towers - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.kaziatherapeutics.com
Webサイト: https://www.kaziatherapeutics.com
